RAPISART-H combines an ARB with a thiazide diuretic for effective blood pressure reduction in hypertensive patients with fluid retention tendencies. Telmisartan provides vasodilation and cardiovascular protection by blocking angiotensin II receptors, while hydrochlorothiazide promotes diuresis to reduce blood volume and lower blood pressure. This combination is particularly beneficial for patients with hypertension who also have edema or are at risk of fluid overload, such as those with heart failure or chronic kidney disease. RAPISART-H offers improved efficacy in blood pressure control while addressing the underlying fluid retention, making it an ideal choice for comprehensive hypertension management.
RAPISART-H: Telmisartan + Hydrochlorothiazide for Hypertension
Category: Tablets
Packaging: 10x10 Alu Alu
Composition: Telmisartan IP 40mg + Hydrochlorothiazide IP 12.5mg
Therapeutic Class: Antihypertensive
Strength: 40mg + 12.5mg per tablet
MRP: ₹1300.00
SCHEDULE H PRESCRIPTION DRUG - WARNING:To be sold by retail on the prescription of a Registered Medical Practitioner only.
Request Info Introduction
Uses & Indications
- Hypertension management
- Edema and fluid retention reduction
- Cardiovascular risk reduction
- Diabetic hypertensive patients
- Metabolic syndrome management
Contraindications
- Pregnancy
- Severe renal disease
- Anuria
Side Effects
The side effects listed below may occur with the use of this medication. However, not all individuals experience these effects.
- Dizziness
- Electrolyte imbalance
- Hyperuricemia
- Fatigue
- Headache
Precautions
- Monitor electrolytes
- Check blood sugar
- Monitor uric acid
Safety Advice & Precautions
- Take with or without food
- Regular electrolyte monitoring advised
- Monitor blood sugar in diabetics
- Avoid NSAIDs if possible
- Rise slowly to prevent dizziness
- Report muscle weakness or cramps
Storage Conditions
Store at temperature not exceeding 25°C. Protect from moisture.
Shelf Life & Expiry
36 months
Frequently Asked Questions
What is the role of the Hydrochlorothiazide (H) component in RAPISART-H?
Hydrochlorothiazide diuretic addition
When is triple therapy with RAPISART-H recommended over single agents?
Often third component in BP management
Does taking RAPISART-H increase the risk of low potassium (hypokalemia)?
Monitor electrolytes regularly
Are there any specific blood sugar precautions for diabetic patients taking RAPISART-H?
Needs careful monitoring of glucose
Medical Disclaimer
This product information is for educational purposes only. It is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always consult with a healthcare professional before starting any new medication or changing your dosage. Rapid Pharmaceuticals is not responsible for any adverse effects resulting from the misuse of this medication.
